pmn310
·Code: PMN310
pmn310: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ProMIS Neurosciences Inc. (PMN) | Phase 1 |
Clinical Trials (1)
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of PMN310 Infusions in Healthy Volunteers
Frequently asked questions
Who is developing pmn310?
pmn310 is being developed by ProMIS Neurosciences Inc..
How many clinical trials involve pmn310?
BioSniper tracks 1 clinical trial involving pmn310.
Get deeper analysis on pmn310
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis